Update Breast Cancer 2023 Part 3 – Expert Opinions of Early Stage Breast Cancer Therapies-Reference-Cited by-同舟云学术

Update Breast Cancer 2023 Part 3 – Expert Opinions of Early Stage Breast Cancer Therapies

Published:2023-09 Issue:09 Volume:83 Page:1117-1126
ISSN:0016-5751
Container-title:Geburtshilfe und Frauenheilkunde
language:de
Short-container-title:Geburtshilfe Frauenheilkd

Author:

Kolberg Hans-Christian¹,Hartkopf Andreas D.²,Fehm Tanja N.³,Welslau Manfred⁴,Müller Volkmar⁵,Schütz Florian⁶,Fasching Peter A.⁷,Janni Wolfgang²,Witzel Isabell⁸,Thomssen Christoph⁹,Beierlein Milena⁷,Belleville Erik¹⁰,Untch Michael¹¹,Thill Marc¹²,Tesch Hans¹³,Ditsch Nina¹⁴,Lux Michael P.¹⁵,Aktas Bahriye¹⁶,Banys-Paluchowski Maggie¹⁷,Kolberg-Liedtke Cornelia¹⁸,Wöckel Achim¹⁹,Harbeck Nadia²⁰,Stickeler Elmar²¹,Bartsch Rupert²²,Schneeweiss Andreas²³,Ettl Johannes²⁴,Krug David²⁵,Taran Florin-Andrei²⁶,Lüftner Diana²⁷²⁸,Würstlein Rachel²⁰

Affiliation:

1. Department of Gynecology and Obstetrics, Marienhospital Bottrop, Bottrop, Germany

2. Department of Gynecology and Obstetrics, Ulm University Hospital, Ulm, Germany

3. Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Düsseldorf, Germany

4. Onkologie Aschaffenburg, Aschaffenburg, Germany

5. Department of Gynecology, Hamburg-Eppendorf University Medical Center, Hamburg, Germany

6. Gynäkologie und Geburtshilfe, Diakonissen-Stiftungs-Krankenhaus Speyer, Speyer, Germany

7. Erlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany

8. Universitätsspital Zürich, Klinik für Gynäkologie, Zürich, Switzerland

9. Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany

10. ClinSol GmbH & Co. KG, Würzburg, Germany

11. Clinic for Gynecology and Obstetrics, Breast Cancer Center, Gynecologic Oncology Center, Helios Klinikum Berlin Buch, Berlin, Germany

12. Agaplesion Markus Krankenhaus, Department of Gynecology and Gynecological Oncology, Frankfurt am Main, Germany

13. Oncology Practice at Bethanien Hospital, Frankfurt am Main, Germany

14. Department of Gynecology and Obstetrics, University Hospital Augsburg, Augsburg, Germany

15. Klinik für Gynäkologie und Geburtshilfe, Frauenklinik St. Louise, Paderborn, St. Josefs-Krankenhaus, Salzkotten, St. Vincenz Krankenhaus GmbH, Paderborn, Germany

16. Department of Gynecology, University of Leipzig Medical Center, Leipzig, Germany

17. Department of Gynecology and Obstetrics, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany

18. Department of Gynecology and Obstetrics, University Hospital Essen, Essen, Germany

19. Department of Gynecology and Obstetrics, University Hospital Würzburg, Würzburg, Germany

20. Breast Center, Department of Gynecology and Obstetrics and CCC Munich LMU, LMU University Hospital, Munich, Germany

21. Department of Obstetrics and Gynecology, Center for Integrated Oncology (CIO Aachen, Bonn, Cologne, Düsseldorf), University Hospital of RWTH Aachen, Aachen, Germany

22. Medical University of Vienna, Department of Medicine I, Division of Oncology, Vienna, Austria

23. National Center for Tumor Diseases, University Hospital and German Cancer Research Center, Heidelberg, Germany

24. Klinikum Kempten, Klinikverbund Allgäu, Klinik für Frauenheilkunde und Gynäkologie, Kempten, Germany

25. Universitätsklinikum Schleswig-Holstein, Campus Kiel, Klinik für Strahlentherapie, Kiel, Germany

26. Department of Gynecology and Obstetrics, University Hospital Freiburg, Freiburg, Germany

27. Immanuel Hospital Märkische Schweiz, Buckow, Germany

28. Medical University of Brandenburg Theodor-Fontane, Brandenburg, Germany

Abstract

AbstractThe St. Gallen (SG) International Breast Cancer Conference is held every two years, previously in St. Gallen and now in Vienna. This year (2023) marks the eighteenth edition of this conference, which focuses on the treatment of patients with early-stage breast carcinoma. A panel discussion will be held at the end of this four-day event, during which a panel of experts will give their opinions on current controversial issues relating to the treatment of early-stage breast cancer patients. To this end, questions are generally formulated in such a way that clinically realistic cases are presented – often including poignant hypothetical modifications. This review reports on the outcome of these discussions and summarises the data associated with individual questions raised.

Publisher

Georg Thieme Verlag KG

Subject

Maternity and Midwifery,Obstetrics and Gynecology

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/a-2143-8125.pdf

Reference59 articles.

1. Pregnancy Outcome and Safety of Interrupting Therapy for women with endocrine responsIVE breast cancer;A H Partridge;San Antonio Breast Cancer Symposium,2022

2. A Population-Based Study of Genes Previously Implicated in Breast Cancer;C Hu;N Engl J Med,2021

3. Breast Cancer Risk Genes – Association Analysis in More than 113,000 Women;Breast Cancer Association Consortium;N Engl J Med,2021

4. Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer;F J Couch;J Clin Oncol,2015

5. Mutations in BRCA1/2 and Other Panel Genes in Patients With Metastatic Breast Cancer-Association With Patient and Disease Characteristics and Effect on Prognosis;P A Fasching;J Clin Oncol,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Impact of Surgical Margin Status on Overall Survival of Patients with Early Breast Cancer: A Retrospective Analysis from the Department for Women’s Medicine at Charité – University Hospital Berlin;Geburtshilfe und Frauenheilkunde;2024-09